These are the largest weight reductions reported for any pharmacological agent in clinical trials
These studies looked at GLP1-RAs in those with obesity and other comorbidities, without T2D, at weight loss doses
Among large firms (more than 200 workers) offering health benefits in 2025, 53% offer workers the opportunity to complete a health risk assessment, 43% offer workers the opportunity to complete a biometric screening, and 83% offer workers one or more wellness programs, such as programs to help them stop smoking or lose weight, or lifestyle and behavioral coaching
1 2 Li H, Lee CH, Yoo KY, Choi JH, Park OK, Yan BC, Byun K, Lee B, Hwang IK, Won MH (December 2010)
Strbe et al., 2021)
We are here to help you